Cargando…

Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors

Novel treatments based upon the use of immune checkpoint inhibitors have an impressive efficacy in different types of cancer. Unfortunately, most patients do not derive benefit or lasting responses, and the reasons for the lack of therapeutic success are not known. Over the past two decades, a press...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibellini, Lara, De Biasi, Sara, Porta, Camillo, Lo Tartaro, Domenico, Depenni, Roberta, Pellacani, Giovanni, Sabbatini, Roberto, Cossarizza, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100547/ https://www.ncbi.nlm.nih.gov/pubmed/32265933 http://dx.doi.org/10.3389/fimmu.2020.00490

Ejemplares similares

Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti‐PD‐1 therapy
por: De Biasi, Sara, et al.
Publicado: (2022)

Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
por: De Biasi, Sara, et al.
Publicado: (2021)

Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival
por: Gibellini, Lara, et al.
Publicado: (2022)

Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab
por: De Biasi, Sara, et al.
Publicado: (2023)

Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions
por: Gibellini, Lara, et al.
Publicado: (2023)

Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
por: Lo Tartaro, Domenico, et al.
Publicado: (2023)

iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles
por: De Biasi, Sara, et al.
Publicado: (2016)

Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial
por: Cossarizza, Andrea, et al.
Publicado: (2023)

A Comprehensive Analysis of Cytokine Network in Centenarians
por: Pinti, Marcello, et al.
Publicado: (2023)

Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
por: Paolini, Annamaria, et al.
Publicado: (2021)

Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancer
por: Aramini, Beatrice, et al.
Publicado: (2022)

The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
por: Franzin, Rossana, et al.
Publicado: (2020)

Evidence for mitochondrial Lonp1 expression in the nucleus
por: Gibellini, Lara, et al.
Publicado: (2022)

Natural Compounds Modulating Mitochondrial Functions
por: Gibellini, Lara, et al.
Publicado: (2015)

LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells
por: Gibellini, Lara, et al.
Publicado: (2018)

Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin
por: Gibellini, Lara, et al.
Publicado: (2010)

Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response
por: Paolini, Annamaria, et al.
Publicado: (2022)

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
por: Gibellini, Lara, et al.
Publicado: (2020)

Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis
por: Gibellini, Lara, et al.
Publicado: (2016)

Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids
por: Borella, Rebecca, et al.
Publicado: (2019)

Increased Plasma Levels of Mitochondrial DNA and Normal Inflammasome Gene Expression in Monocytes Characterize Patients With Septic Shock Due to Multidrug Resistant Bacteria
por: Busani, Stefano, et al.
Publicado: (2020)

Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells
por: Carenza, Claudia, et al.
Publicado: (2019)

Impaired Mitochondrial Morphology and Functionality in Lonp1(wt/−) Mice
por: De Gaetano, Anna, et al.
Publicado: (2020)

Quercetin and Cancer Chemoprevention
por: Gibellini, Lara, et al.
Publicado: (2011)

Reliable and Accurate CD4+ T Cell Count and Percent by the Portable Flow Cytometer CyFlow MiniPOC and “CD4 Easy Count Kit-Dry”, as Revealed by the Comparison with the Gold Standard Dual Platform Technology
por: Nasi, Milena, et al.
Publicado: (2015)

A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer
por: Yan, Yi-Dan, et al.
Publicado: (2021)

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events
por: Müller-Jensen, Leonie, et al.
Publicado: (2023)

Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study
por: Agrati, Chiara, et al.
Publicado: (2023)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis
por: Westdorp, Harm, et al.
Publicado: (2021)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
por: von Knethen, Andreas, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021)

Advances in immune checkpoint inhibitors induced-cardiotoxicity
por: Li, Xiang, et al.
Publicado: (2023)

Cutaneous manifestations associated with immune checkpoint inhibitors
por: Watanabe, Tomoya, et al.
Publicado: (2023)

Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia
por: Lo Tartaro, Domenico, et al.
Publicado: (2022)

CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
por: Han, Rui, et al.
Publicado: (2023)

Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells
por: Gibellini, Lara, et al.
Publicado: (2015)

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
por: De Biasi, Sara, et al.
Publicado: (2020)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
por: Yan, Yiyi, et al.
Publicado: (2018)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
por: Xu, Ya, et al.
Publicado: (2020)

Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis
por: Lin, Xinqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e9tr48ph7olru7q1lm5je1rim4